Agios Pharmaceuticals Inc (NASDAQ: AGIO) on Friday, soared 3.08% from the previous trading day, before settling in for the closing price of $44.14. Within the past 52 weeks, AGIO’s price has moved between $19.80 and $53.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 2.66% annually for the last half of the decade. The company achieved an average annual earnings per share of 280.79%. With a float of $55.15 million, this company’s outstanding shares have now reached $55.95 million.
In an organization with 383 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 75.45%, operating margin of -1293.88%, and the pretax margin is -1165.69%.
Agios Pharmaceuticals Inc (AGIO) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Agios Pharmaceuticals Inc is 3.06%, while institutional ownership is 101.64%. The most recent insider transaction that took place on Sep 26 ’24, was worth 124,634. In this transaction Chief Financial Officer of this company sold 2,542 shares at a rate of $49.03, taking the stock ownership to the 20,158 shares. Before that another transaction happened on Aug 08 ’24, when Company’s Chief Executive Officer sold 11,091 for $42.75, making the entire transaction worth $474,140. This insider now owns 78,792 shares in total.
Agios Pharmaceuticals Inc (AGIO) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -1.64 earnings per share (EPS) for the period topping the consensus outlook (set at -1.7) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 280.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.00% during the next five years compared to -0.98% drop over the previous five years of trading.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators
Agios Pharmaceuticals Inc (AGIO) is currently performing well based on its current performance indicators. A quick ratio of 9.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 82.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.49, a number that is poised to hit 15.22 in the next quarter and is forecasted to reach -6.11 in one year’s time.
Technical Analysis of Agios Pharmaceuticals Inc (AGIO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.48 million. That was inferior than the volume of 0.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 90.39%. Additionally, its Average True Range was 1.92.
During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 54.59%, which indicates a significant decrease from 88.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.62% in the past 14 days, which was lower than the 49.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.58, while its 200-day Moving Average is $36.78. However, in the short run, Agios Pharmaceuticals Inc’s stock first resistance to watch stands at $46.48. Second resistance stands at $47.47. The third major resistance level sits at $48.74. If the price goes on to break the first support level at $44.22, it is likely to go to the next support level at $42.95. The third support level lies at $41.96 if the price breaches the second support level.
Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats
Market capitalization of the company is 2.59 billion based on 56,773K outstanding shares. Right now, sales total 26,820 K and income totals -352,090 K. The company made 8,620 K in profit during its latest quarter, and -96,120 K in sales during its previous quarter.
